Chemical Structure : Cibisatamab
CAS No.: 2101242-53-7
货号: PC-Ab1057Not For Human Use, Lab Use Only.
Cibisatamab (CEA-TCB, RO-6958688) is a novel bispecific antibody immunotherapy that effectively brings the cancer cells and cancer-killing T cells of the immune system together, triggers T cell killing of cancer cell lines expressing moderate to high levels of CEA at the cell surface. It is efficacious in poorly infiltrated tumors where it increases T-cell infiltration and generates a highly inflamed tumor microenvironment..
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥3580 | In stock | |
5 mg | ¥7580 | In stock | |
10 mg | ¥12800 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Cibisatamab (CEA-TCB, RO-6958688) is a novel bispecific antibody immunotherapy that effectively brings the cancer cells and cancer-killing T cells of the immune system together, triggers T cell killing of cancer cell lines expressing moderate to high levels of CEA at the cell surface. It is efficacious in poorly infiltrated tumors where it increases T-cell infiltration and generates a highly inflamed tumor microenvironment.
分子量 | ||
分子式 | Human IgG1-Kappa | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
PBS, pH 7.0 Contains no stabilizers or preservatives |
|
Chemical Name/SMILES |
Cibisatamab; CEA-CD3 TCB; CEA-TCB; RG-7802; RO-6958688; CD66e; Carcinoembryonic antigen (CEA); CEACAM5; 2101242-53-7 |
1. 1, Van De Vyver AJ, et al. Mol Cancer Ther. 2021 Feb;20(2):357-366. 2, Gonzalez-Exposito R, et al. J Immunother Cancer. 2019 Apr 15;7(1):101. 3, Marina Bacac, et al. Clin Cancer Res . 2016 Jul 1;22(13):3286-97.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright